Goodwin Procter advised G Squared Ascend I on the deal. Latham & Watkins represented Transfix. G Squared Ascend I (NYSE: GSQD), a special purpose acquisition company...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Forge Global on the deal. Forge Global announced its definitive merger agreement with Motive Capital Corp (NYSE: MOTV.U) sponsored by affiliates of Motive Partners....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised SWORD Health on the deal. SWORD Health announced the completion of its $85 million Series C funding round led by General Catalyst. Other participating...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Hopin on the deal. Hopin, one of the fastest growing startups in Europe, completed its $450 million Series D funding round led by...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised EQRx on the deal while White & Case LLP advised CM Life Sciences III Inc. EQRx, Inc. announced its definitive merger agreement with CM...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised GeneWerk on the deal. GeneWerk announced its merger with Protagen Protein Services. GeneWerk, an Ampersand portfolio company, is a cell and gene therapy testing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Symphony on the deal while Wilmer Cutler Pickering Hale and Dorr represented Cloud9 Technologies. Symphony announced its acquisition of Cloud9 Technologies. Symphony is...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised TrueMotion on the deal. TrueMotion announced its acquisition by Cambridge Mobile Telematics. The transaction, which closed on June 16, unites the two leading...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Valo Health on the deal, while Latham & Watkins LLP represented Khosla Ventures Acquisition Co. Valo Health announced its definitive merger agreement with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Klaviyo on the deal. Klaviyo announced its $320 million Series D financing. Klaviyo is a leading customer data and marketing automation platform. By...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Klaviyo on the deal. Klaviyo announced its $320 million Series D financing. Klaviyo is a leading customer data and marketing automation platform. By...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Better Therapeutics, Inc. on the deal. Better Therapeutics, Inc. announced its definitive merger agreement with Mountain Crest Acquisition Corp II (Nasdaq: MCAD;), a...
You must be a Standard 1 Year member to access this content.
